Oberweis Asset Management »

Indivior Pharmaceuticals shares owned by Oberweis Asset Management

Quarter-by-quarter ownership of Indivior Pharmaceuticals (INDV) shares owned by Oberweis Asset Management from 13F filings

Historical chart of Oberweis Asset Management investment in Indivior Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Indivior Pharmaceuticals held by Oberweis Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Indivior Pharmaceuticals by Oberweis Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $20M 653k 30.48

More positions owned by Oberweis Asset Management

Applied Optoelectronics (AAOI)
Lumentum Hldgs (LITE)
Credo Technology Group Holding (CRDO)
Digitalocean Hldgs (DOCN)
Sharkninja (SN)
NOVA MEASURING Instruments L (NVMI)
Dana Holding Corporation (DAN)
Brightspring Health Svcs (BTSG)
M/a (MTSI)
Rambus (RMBS)
Clean Harbors (CLH)
Sitime Corp (SITM)
Ultra Clean Holdings (UCTT)
Everus Constr Group (ECG)
Frontdoor (FTDR)

View all positions for Oberweis Asset Management

Top funds holding Indivior Pharmaceuticals

BlackRock
Vanguard Portfolio Management
Oaktree Capital Management
Vanguard Capital Management
State Street Corporation
Two Seas Capital
Millennium Management
Hanna Zanoni
Madison Avenue Partners
Citadel Advisors
Morgan Stanley
Deerfield Management Company
Geode Capital Management
Mangrove Partners
Goldman Sachs Group

View all funds holding Indivior Pharmaceuticals